Keith Syson Chan
Impact in
- Oncology top 1%
- Cytokine Signaling Pathways and Interactions
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Immunology top 2%
- Psoriasis: Treatment and Pathogenesis
Papers in
- Oncology 27
- Cytokine Signaling Pathways and Interactions 10
- Cancer Cells and Metastasis 6
- CAR-T cell therapy research 5
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- John DiGiovanni (10 shared papers)Shigetoshi Sano (8 shared papers)Kaoru Kiguchi (7 shared papers)Steve Carbajal (5 shared papers)Philip Levy Ho (5 shared papers)Antonina V. Kurtova (7 shared papers)John L. Clifford (3 shared papers)Qianxing Mo (8 shared papers)
- Journals
- Nature Communications (7 papers)Cancer Research (4 papers)Proceedings of the National Academy of Sciences (3 papers)Transplantation and Cellular Therapy (2 papers)JNCI Journal of the National Cancer Institute (2 papers)
- Partner nations
- United StatesJapanTaiwan
In The Last Decade
Keith Syson Chan
52 papers receiving 5.1k citations
Keith Syson Chan's Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 1.9k
- Immunology 1.2k
- Cancer Research 794
- Dermatology 364
- Molecular Biology 2.1k
Countries citing papers authored by Keith Syson Chan
This map shows the geographic impact of Keith Syson Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Syson Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Syson Chan more than expected).
Fields of papers citing papers by Keith Syson Chan
This network shows the impact of papers produced by Keith Syson Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Syson Chan. The network helps show where Keith Syson Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Keith Syson Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 638 | |
| 2 | Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells Hit paper breakdown → | 2009 | 538 |
| 3 | Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance Hit paper breakdown → | 2014 | 481 |
| 4 | 2004 | 284 | |
| 5 | 2004 | 276 | |
| 6 | 2020 | 229 | |
| 7 | 2012 | 206 | |
| 8 | 2017 | 192 | |
| 9 | 2016 | 168 | |
| 10 | 2007 | 154 | |
| 11 | Constitutive expression of ErbB-2 in gallbladder epithelium results in development of adenocarcinoma. | 2001 | 154 |
| 12 | 2012 | 151 | |
| 13 | 2004 | 151 | |
| 14 | 2021 | 123 | |
| 15 | 2014 | 120 | |
| 16 | 2012 | 115 | |
| 17 | 2018 | 112 | |
| 18 | 2007 | 97 | |
| 19 | 2007 | 93 | |
| 20 | 2005 | 85 |
About Keith Syson Chan
Keith Syson Chan is a scholar working on Oncology, Cancer Research, Molecular Biology, Immunology and Surgery, having authored 54 papers that have together received 5.2k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (13 papers), Cytokine Signaling Pathways and Interactions (10 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), Epigenetics and DNA Methylation (8 papers), Cancer Cells and Metastasis (6 papers), CAR-T cell therapy research (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Urinary and Genital Oncology Studies (5 papers). The work is most often cited by research in Oncology (1.9k citations), Immunology (1.2k citations), Cancer Research (794 citations), Dermatology (364 citations) and Molecular Biology (2.1k citations). Keith Syson Chan has collaborated with scholars based in United States, Japan and Taiwan. Frequent co-authors include John DiGiovanni, Shigetoshi Sano, Kaoru Kiguchi, Steve Carbajal, Philip Levy Ho, Antonina V. Kurtova, John L. Clifford, Qianxing Mo, Junji Takeda and Irving L. Weissman. Their work appears in journals such as Nature Communications, Cancer Research, Proceedings of the National Academy of Sciences, Transplantation and Cellular Therapy and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.